⏳ Fetching live dividend data...
Home › Calculator › ATRS Dividend Calculator 2026
Antares Pharma, Inc. · NASDAQ
Price: $5.59 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ATRS → $14.36M in 10 years · $417.92/month
Antares Pharma, Inc. operates as a specialized pharmaceutical enterprise, primarily dedicated to innovating and marketing medicines and advanced technologies. Its core mission is to address critical patient needs across a range of therapeutic areas. The company achieves this by developing, manufacturing, and commercializing groundbreaking therapeutic products, often leveraging its distinctive drug delivery systems. A significant portion of its product lineup involves injectable solutions. This includes XYOSTED, a subcutaneous therapy for testosterone replacement in adult men, and OTREXUP, an injectable methotrexate formulation used to manage severe active rheumatoid arthritis, active polyarticular juvenile idiopathic arthritis in children, and severe recalcitrant psoriasis in adults. While primarily known for its injectable portfolio, Antares also offers NOCDURNA sublingual tablets, prescribed for adults experiencing nocturia due to nocturnal polyuria, where they awaken multiple times nightly to urinate. Further expanding its therapeutic offerings, the company provides generic Epinephrine Injection USP for the urgent treatment of severe allergic reactions, including anaphylaxis, applicable to adults and certain pediatric patients. Other key products include Sumatriptan Injection USP for the acute management of migraine and cluster headaches in adults, and the Makena subcutaneous auto-injector, designed to lower the risk of preterm birth in women. Additionally, Antares markets Teriparatide injection for osteoporosis, addressing both postmenopausal women and men at heightened fracture risk, as well as those with glucocorticoid-induced osteoporosis. Beyond existing medications, Antares Pharma is actively involved in the development of various drug delivery devices, such as disposable pen injectors for diabetes and osteoporosis, and QuickShot auto-injectors. It is also advancing TLANDO for the treatment of testosterone deficiency in adult males, alongside other innovative drug/device combinations targeting urologic oncology, immunology, and endocrinology. The company has established strategic alliances and collaborative partnerships with prominent pharmaceutical entities like Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Founded in 1979 and headquartered in Ewing, New Jersey, Antares Pharma, Inc. transitioned into a subsidiary of Halozyme Therapeutics, Inc. as of May 23, 2022.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ATRS position with:
Real after-tax yield depends on where you live and how you hold ATRS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 35.78% | 32.98% | $3,578 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 30.41% | 27.61% | $3,041 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 28.62% | 25.82% | $2,862 / yr |
| 🇬🇧 UK ISA | 0% | 35.78% | 32.98% | $3,578 / yr |
| 🇬🇧 UK Taxable | 8.75% | 32.65% | 29.85% | $3,265 / yr |
| 🇨🇦 TFSA | 0% | 35.78% | 32.98% | $3,578 / yr |
| 🇨🇦 CA Taxable | 25% | 26.84% | 24.04% | $2,684 / yr |
| 🇦🇺 Super (pension) | 15% | 30.41% | 27.61% | $3,041 / yr |
| 🇦🇺 AU Taxable | 30% | 25.05% | 22.25% | $2,505 / yr |
| 🇩🇪 DE Taxable | 26.375% | 26.34% | 23.54% | $2,634 / yr |
| 🇫🇷 FR Taxable | 30% | 25.05% | 22.25% | $2,505 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ATRS pays quarterly — 4 times per year. Next ex-div: TBD.
How ATRS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ATRS sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ATRS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Antares Pharma, Inc. (ATRS) is currently trading at $5.59, trading near its 52-week high. The current dividend yield is 35.78% based on an annual payout of $2.00 per share.
Antares Pharma, Inc. (ATRS) is a healthcare stock currently trading at $5.59 with a dividend yield of 35.78%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →